Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2026-02-21 @ 10:10 AM
Study NCT ID:
NCT00945035
Status:
COMPLETED
Last Update Posted:
2022-02-09
First Post:
2009-07-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of the Bioequivalence of the 20% and 30% Etoricoxib Tablet Formulations (0663-070)
Sponsor:
Organon and Co
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
0663-070
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None